SEC Form 4 research
| Issuer | Evogene Ltd. |
|---|---|
| Tickers | EVGN |
| Reporting owners | 12 |
| Officers and directors | 2 |
| Last public filing | 2026-09-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-30 | 2026-09-04 | RECANATI LEON | A | 2,500 | $0 | Not reported |
| 2026-09-30 | 2026-09-04 | Nimrodi Nir | A | 10,000 | $0 | Not reported |
| 2026-09-30 | 2026-09-04 | Percy Adrian John | A | 2,500 | $0 | Not reported |
| 2026-09-30 | 2026-09-04 | Falk Dan Michael | A | 2,500 | $0 | Not reported |
| 2026-08-26 | 2026-06-04 | Tarcic Gabi | P | 1,129 | $0.6 | Not reported |
| 2026-08-13 | 2026-08-11 | RECANATI LEON | P | 460,000 | $0.64 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.